Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) Initiated
A Phase I trial is underway to evaluate the safety and efficacy of high-density theta burst stimulation (hdTBS) in healthy adults.
Phase I
Neurology / Depression
Status
Initiated
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The initiation of the Phase I trial for high-density theta burst stimulation (hdTBS) is significant as it may enhance treatment options for major depression, potentially reshaping current therapeutic approaches. Success in this trial could lead to a competitive advantage in the neuromodulation market.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results for safety and efficacy data, as well as any subsequent trials planned for depressed populations.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.